WEBULL
News
ASND
213.29
+0.02%
0.05
Ascendis Pharma Ups Share Capital After Warrant Exercises in December 2025
TipRanks · 12/30/2025 21:43
Weekly Report: what happened at ASND last week (1222-1226)?
Weekly Report · 12/29/2025 10:02
BridgeBio Has More Room To Run
Seeking Alpha · 12/23/2025 17:41
BioMarin: Amicus Buyout Sparks My Enthusiasm
Seeking Alpha · 12/22/2025 20:15
Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Disc Medicine (IRON) and Ascendis Pharma (ASND)
TipRanks · 12/22/2025 14:00
Weekly Report: what happened at ASND last week (1215-1219)?
Weekly Report · 12/22/2025 10:01
Ascendis Pharma (ASND): Revisiting Valuation After Recent Pullback and Strong 1-Year Shareholder Returns
Simply Wall St · 12/19/2025 19:34
Evercore ISI Sticks to Its Buy Rating for Ascendis Pharma (ASND)
TipRanks · 12/18/2025 15:25
Here's How Much $1000 Invested In Ascendis Pharma 10 Years Ago Would Be Worth Today
Benzinga · 12/15/2025 22:00
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ascendis Pharma (ASND), Galapagos (GLPG) and Stevanato Group (STVN)
TipRanks · 12/15/2025 14:01
Weekly Report: what happened at ASND last week (1208-1212)?
Weekly Report · 12/15/2025 10:07
Here's My Prediction For Who Could Acquire Ascendis Pharma
Seeking Alpha · 12/15/2025 08:18
Can Ascendis Pharma Still Offer Value After 2025 Rally and Endocrinology Milestones?
Simply Wall St · 12/15/2025 02:19
$100 Invested In Ascendis Pharma 10 Years Ago Would Be Worth This Much Today
Benzinga · 12/12/2025 20:45
Ascendis Pharma gains amid takeover speculation
Seeking Alpha · 12/12/2025 20:24
Ascendis Pharma rumor highlighted in Betaville blog
TipRanks · 12/12/2025 20:15
Looking Into Ascendis Pharma AS's Recent Short Interest
Benzinga · 12/12/2025 19:00
March 2026 Options Now Available For Ascendis Pharma (ASND)
NASDAQ · 12/12/2025 15:43
Eight stock picks to play one of the healthiest corners of the market
MarketWatch · 12/11/2025 15:37
Ascendis Pharma Is Maintained at Buy by Stifel
Dow Jones · 12/11/2025 13:34
More
Webull provides a variety of real-time ASND stock news. You can receive the latest news about Ascendis Pharma through multiple platforms. This information may help you make smarter investment decisions.
About ASND
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).